General
AstraZeneca’s COVID-19 vaccine rebranding to ‘Vaxzevria’ ahead of international travel restart
AstraZeneca has become a household name, but its COVID-19 vaccine will soon be rebranded to help smooth the pathway for millions of Australians hoping to travel overseas once the international border reopens.
Key points:
- The AstraZeneca COVID-19 vaccine in Australia will be renamed Vaxzevria to…
Continue Reading
-
Noosa News23 hours agoCalls for greater education as growers in WA’s south-west brace for polyphagous shot-hole borer
-
Business23 hours agoWhat it means for shareholders
-
General22 hours agoKim Kardashian not deterred by bar failure
-
Business16 hours agoMacquarie tips more than 20% upside for this ASX mining stock
